Common TRAE: nausea, diarrhea, AST/ALT increaseGrade 5 TRAE: pneumonitis and pneumoniaTRAE to d/c regimen: 4% for both, 6% for adagrasib, and 11% for pembrolizumab. Here, GPT is linked to pneumonitis.